This compound is a protected intermediate for modified nucleosides, featuring a silyl-protected ribose moiety and a trityl-type protecting group. It is used in the synthesis of nucleoside analogs for pharmaceutical research and manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 875302-41-3
5'-O-(4,4'-dimethoxitrityl)-3'-O-(tert-butyldimethylsilyl)-1-methylpseudouridine
pharmaceutical intermediate
5'-O-(4,4'-dimethoxitrityl)-1-N-methylpseudouridine
pharmaceutical intermediate
5'-O-DMT-2'-O-TBDMS-Pseudouridine
pharmaceutical intermediate
5'-DMT-3'-O-TBDMS-N1-Me-Pseudouridine-CE-Phosphoramidite
pharmaceutical intermediate
Secukinumab
pharmaceutical intermediate
(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one
pharmaceutical intermediate
(4-Fluoro-5-isopropyl-2-methoxyphenyl)boronic acid
pharmaceutical intermediate
5'-DMT-3'-O-TBDMS-PseudoUridine
pharmaceutical intermediate
5-[(2S,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxyoxolan-2-yl]-1-methylpyrimidine-2,4-dione
LAUAFECHUGXCAW-NXVJRICRSA-N
CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H]([C@H](O[C@H]1C2=CN(C(=O)NC2=O)C)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O
—